Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized multicentre trial

Bibliographic Details
Title: Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized multicentre trial
Authors: Karoui, Mehdi, Gallois, Claire, Piessen, Guillaume, Legoux, Jean‐Louis, Barbier, Emilie, De Chaisemartin, Cecile, Lecaille, Cedric, Bouche, Olivier, Ammarguellat, Hanifa, Brunetti, Francesco, Prudhomme, Michel, Regimbeau, Jean‐Marc, Glehen, Olivier, Lievre, Astrid, Portier, Guillaume, Hartwig, Johannes, Goujon, Gael, Romain, Benoit, Lepage, Come, Taieb, Julien, Ainseba, N., Alcaraz, L., Audemar, F., Bachet, J. B., Bardier, A., Baumgaertner, I., Luciani, A., Bège, T., Ben Abdelghani, M., Bourgeois, V., Brigand, C., Couteau, C., Champetier, C., Chauvenet, M., Debourdeau, P., Deguelte, S., Poizat, F., Sarran, A, Deplanque, G., Olivier, D., Duluc, M., Faucheron, J. L., François, Y., Freddy, M., Gasmi, M., Gornet, J. M., Gualtierotti, M., Lacaze, L., Lagasse, J. P., Lepere, C., Loriau, J., Malaurie, E., Manfredi, S., Mauvais, F., Meunier, B., Mineur, L., N'Guyen, S., Obled, S., Oden Gangloff, A., Ollier, J. C., Pelletier, A. L., Pere Verge, D., Peschaud, F., Pezet, D., Ramdani, M., Ries‐guye, P., Rougier, P., Rullier, E., Sabbagh, C., Saudemont, A., Seitz, J. F., Sobhani, I., Tessier, W., Tougeron, D.
Source: Colorectal disease. 23(6):1357-1369
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121652581.0x000001&indx=1&recIds=ETOCvdc_100121652581.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:14628910
Published in:Colorectal disease
Language:English